Clinical Trials
13 trialsNCT04209868 2024-03-29
ParaSOL
Guy's and St Thomas' NHS Foundation Trust
Phase 2/3 Unknown
NCT02871856 2023-12-05
ILST
The University of Queensland
Phase NA Unknown
NCT05321615 2023-10-25
Palpator
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Unknown
NCT05988736 2023-08-14
Comparison Between McGrath and Macintosh Laryngoscopes for DLT Intubation in Thoracic Surgery Patients.
Aga Khan University
Phase NA Unknown
NCT03634982 2022-09-01
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Unknown
NCT03521986 2022-05-11
Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS
Shanghai Pulmonary Hospital, Shanghai, China
Phase 3 Unknown
NCT04725448 2021-04-06
Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT03402048 2020-11-04
EPIC
University of Turin, Italy
Phase 3 Unknown
NCT04371796 2020-05-01
Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT04133337 2019-10-21
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 1/2 Unknown
NCT03389256 2018-01-03
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT03168048 2017-05-30
OPTIMISE-1
Heidelberg University
Phase NA Unknown
NCT03083743 2017-03-20
A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection
Shanghai Gebaide Biotechnology Co., Ltd.
Phase 3 Unknown